1st Edition

Silver Nanoparticles for Antibacterial Devices Biocompatibility and Toxicity

Edited By Huiliang Cao Copyright 2017
    504 Pages 32 Color & 94 B/W Illustrations
    by CRC Press

    478 Pages 32 Color & 94 B/W Illustrations
    by CRC Press

    478 Pages 32 Color & 94 B/W Illustrations
    by CRC Press

    Since the potential toxicity of silver nanoparticles (Ag NPs) has raised serious concerns in the biomaterials and biomedical engineering community, Silver Nanoparticles for Antibacterial Devices: Biocompatibility and Toxicity brings together the synthesis, the physicochemical properties and the biological actions of Ag NPs, as well as the clinical demands for fabricating antibacterial medical devices, discussing how to suppress the side effects of nanomaterials and how to impart to them the selective toxicity. This book presents the two primary paradigms that have emerged in probing the antibacterial applications of Ag NPs, i.e. the active attacking releasing way and the conservative defending approach by taking advantage of various short-range actions; it shows readers how the ways in which Ag NPs have behaved can be engineered purposively.

    With contributions from leading international experts and extensive references listed in each chapter, this volume provides the general principles on controlling the physicochemical behaviors of nanomaterials and managing their toxicity risks.

    SECTION I: Synthesis and Assembling

    Chapter 1: Bioinspired Synthesis of Silver Nanoparticles: Characterization, Mechanism and Applications

    Chapter 2: Tuning the Properties of Silver Monolayer for Biological Applications

    Chapter 3: Synergistic Antimicrobial Activity of Silver and Chitosan

    Chapter 4: Titania Nanotubes as Silver Nanoparticle Carriers to Prevent Implant-associated Infection

    Chapter 5: Polymer-silver Nanocomposites: Preparation, Characterization and Antibacterial Mechanism


    SECTION II: The Risk of Silver

    Chapter 6: Dissolution of Silver Nanoparticles

    Chapter 7: Silver as an antimicrobial agent: the Resistance Issue

    Chapter 8: The Risks of Silver Nanoparticles to Human Body

    Chapter 9: Imunomodulatory Activities of Silver nanoparticles (Ag NPs) in Human Neutrophils


    SECTION III: Techniques and Concepts for Risk Control

    Chapter 10: Evaluating the Interactions of Silver Nanoparticles and Mammalian Cells Based on Biomices Technologies

    Chapter 11: Methods and Tools for Assessing Nanomaterials and Uses and Regulation of Nanosilver in Europe

    Chapter 12: Toward Selectively Toxic Silver Nanoparticles


    SECTION IV: Clinical Demands

    Chapter 13: Orthopaedic Implant-associated Infections: Pathogenesis, Clinical Presentation and Management

    Chapter 14: Dental Implant Infection: Typical Causes and Control

    Chapter 15: Guidelines for Nanosilver-based Antibacterial Devices


    Huiliang Cao